Karlis Trusinskis Selected Research

Fluspirilene (Imap)

1/2020	Circulating plasma microRNA-126, microRNA-145, and microRNA-155 and their association with atherosclerotic plaque characteristics.
6/2015	In-vivo iMap IVUS comparison of in-stent neointima and native coronary atherosclerosis.
3/2014	Plaque and blood vulnerability in ST segment elevation myocardial infarction patients: association between lesion morphology using intravascular ultrasound radiofrequency analysis and circulating biomarkers.
3/2013	iMap intravascular ultrasound evaluation of culprit and non-culprit lesions in patients with ST-elevation myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karlis Trusinskis Research Topics

Disease

3	Coronary Artery Disease (Coronary Atherosclerosis) 04/2021 - 06/2015
3	ST Elevation Myocardial Infarction 06/2015 - 03/2013
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 01/2020
1	Vascular Remodeling 04/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2021
1	Atherosclerosis 01/2020
1	Neointima 06/2015
1	Infarction (Infarctions) 03/2014
1	Coronary Disease (Coronary Heart Disease) 01/2003

Drug/Important Bio-Agent (IBA)

4	Fluspirilene (Imap)IBA 01/2020 - 03/2013
2	Biomarkers (Surrogate Marker)IBA 04/2021 - 03/2014
2	MicroRNAs (MicroRNA)IBA 04/2021 - 01/2020
1	LipidsIBA 01/2022
1	Circulating MicroRNAIBA 04/2021
1	Plasminogen Activator Inhibitor 1IBA 03/2014
1	HomocysteineIBA 01/2003
1	KynurenineIBA 01/2003
1	Tryptophan (L-Tryptophan)FDA Link 01/2003
1	NeopterinIBA 01/2003

Therapy/Procedure

1	Therapeutics 01/2022
1	Percutaneous Coronary Intervention 01/2020
1	Stents 06/2015